LifeMD, Inc. (LFMD)

NGM – Real vaqt narxi. Valyuta: USD

4.13

-0.07 (-1.67%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

4.11

-0.02 (-0.47%)

Bozordan keyin: Jun 26, 2026, 7:52 PM EDT

01.06.2026

LifeMD Appoints Umesh Sripad as Chief Technology Officer

Seasoned Technology Executive Brings More Than Two Decades of Large-Scale Digital Transformation Experience to Support LifeMD's Next Phase of Growth Seasoned Technology Executive Brings More Than Two Decades of Large-Scale Digital Transformation Experience to Support LifeMD's Next Phase of Growth

15.05.2026

LifeMD to Participate in Upcoming Investor Conferences

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming investor conferences.

07.05.2026

LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript

06.05.2026

LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to earnings of $0.01 per share a year ago.

06.05.2026

LifeMD Reports First Quarter 2026 Results

First quarter 2026 revenue of $50.2 million and adjusted EBITDA loss of $4.5 million, above and in line, respectively, with the Company's guidance. Gross margin increased approximately 420 basis points to 88%, versus the first quarter of 2025, reflecting favorable revenue mix and lower fulfillment costs.

27.04.2026

LifeMD to Report First Quarter 2026 Financial Results on May 6

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2026, after the close of the U.S. financial markets on May 6, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.

21.04.2026

LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?

LifeMD (LFMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Videolar

No Data

There is no data to display

LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect® LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect®

31.03.2026

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

Delivering up to $1,200 in annual patient savings on branded GLP-1 therapy, expanding LifeMD's collaboration with Novo Nordisk Delivering up to $1,200 in annual patient savings on branded GLP-1 therapy, expanding LifeMD's collaboration with Novo Nordisk

LifeMD, Inc. (LFMD)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

LifeMD, Inc. (LFMD)

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LifeMD to Participate in Upcoming Investor Conferences

LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript

LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates

LifeMD Reports First Quarter 2026 Results

LifeMD to Report First Quarter 2026 Financial Results on May 6

LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?

Videolar

No Data

Press-relizlar

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LifeMD Reports First Quarter 2026 Results

LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LifeMD to Participate in Upcoming Investor Conferences

LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript

LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates

LifeMD Reports First Quarter 2026 Results

LifeMD to Report First Quarter 2026 Financial Results on May 6

LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?

Videolar

No Data

Press-relizlar

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LifeMD Reports First Quarter 2026 Results

LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

Search stocks

LifeMD, Inc. (LFMD)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

LifeMD, Inc. (LFMD)

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LifeMD to Participate in Upcoming Investor Conferences

LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript

LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates

LifeMD Reports First Quarter 2026 Results

LifeMD to Report First Quarter 2026 Financial Results on May 6

LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?

Videolar

No Data

Press-relizlar

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LifeMD Reports First Quarter 2026 Results

LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LifeMD to Participate in Upcoming Investor Conferences

LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript

LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates

LifeMD Reports First Quarter 2026 Results

LifeMD to Report First Quarter 2026 Financial Results on May 6

LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?

Videolar

No Data

Press-relizlar

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LifeMD Reports First Quarter 2026 Results

LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program